LIGAND PHARMACEUTICALS INCORPORATED AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 22, 2018Indenture • May 22nd, 2018 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of May 22, 2018, between LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01) and WILMINGTON TRUST, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
ContractSecond Supplemental Indenture • May 22nd, 2018 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of May 22, 2018, between Ligand Pharmaceuticals Incorporated, a Delaware corporation (the “Company”), and Wilmington Trust, National Association, as trustee under the Indenture referred to below (the “Trustee”).
